North America
-
Working Paper
Considering Returns on Federal Investment in the Negotiated “Maximum Fair Price” of Drugs Under the Inflation Reduction Act: an Analysis
Mar 2024
The empirical analysis of public sector investments and the health value created by the drugs selected for Medicare price negotiations provides a cost basis for the assessment of the maximum fair price.
-
Working Paper
Mapping Fragility – Functions of Wealth and Social Classes in US Household Finance
Jan 2024
Examining the crucial role of poverty and inequality in shaping household indebtedness.
-
Working Paper
Monopsony in Professional Labor Markets: Hospital System Concentration and Nurse Wages
Jan 2023
Increased hospital system consolidation in small Metropolitan Statistical Areas is adversely related to nurse wage growth.
-
Meet the Grinch Stealing the Future of Gen Y And Z
Dec 20, 2022
Salaries in the U.S. aren’t keeping up with inflation, despite pandemic-related increases in some sectors. That’s a major threat to the future for all working Americans – especially the youngest.
-
Bankman-Fried, Political Money, and the Crash of FTX
Dec 15, 2022
How Showering Money on Both Parties Paralyzed Regulators
-
Working Paper
Why Economists Should Support Populist Antitrust Goals
Dec 2022
The Consumer Welfare Standard is severely limited or defective, preventing it from being an appropriate standard for modern antitrust.
-
Top Economist: America’s Racist Economy Getting Worse, Not Better
Mar 8, 2022
Lynn Parramore explores Peter Temin’s new book on the country’s two economic histories: progress for whites, slavery and segregation for Black people. He warns of a second-tier global future unless they come together.
-
Where Did You Go, Vice President Joe?
Mar 4, 2022
President Biden’s first SOTU Address was a missed opportunity to say what he knows to be true: Stock buybacks manipulate the market and leave most Americans worse off
-
Beyond Price Caps: A Regulatory Framework for Pricing of Medicine Innovation
Feb 3, 2022
US regulators can step in to ensure drug pricing both supports patient access and drug development
-
Working Paper Series
Pricing for Medicine Innovation: A Regulatory Approach to Support Drug Development and Patient Access
Feb 2022
US regulators can step in to ensure drug pricing both supports patient access and drug development
-
Mexico’s Auto Industry Between Radical Change and Trade Wars
Oct 26, 2021
Between a rock and a hard place
-
Working Paper Series
Mexico’s Automotive Industry: A Success Story?
Oct 2021
Between a rock and a hard place
-
Does America Want a CHIPS for Buybacks Act?
Oct 4, 2021
To strengthen the American semiconductor industry, Congress should condition additional funds on suspending stock buybacks
-
Working Paper Series
Why the CHIPS Are Down: Stock Buybacks and Subsidies in the U.S. Semiconductor Industry
Oct 2021
To strengthen the American semiconductor industry, Congress should condition additional funds on suspending stock buybacks
-
Why Aren’t Libertarians Protesting the Freedom-Busting Texas Abortion Law?
Sep 8, 2021
On deregulation and Covid masks, libertarians are loud. On female liberty, deafening silence.